ANS Testing recommended as standard of care by:
•American Diabetes Association • American Heart Association • American Academy of Family Physicians • Juvenile Diabetes Research Foundation International • American Academy of Neurology • National Heart, Lung, and Blood Institute • National Diabetes, Digestive and Kidney Diseases
The IntelleWave is a non-invasive cardiac monitoring device that provides Quantitative assessment of the Autonomic Nervous System (ANS) via Heart Rate Variability (HRV) and blood pressure analysis. The system is used to objectively confirm or exclude a Cardiovascular Autonomic Neuropathy (CAN), a Diabetic Autonomic Neuropathy (DAN)and other dysautonomia problems. It is able to recognized Beta-Blockers over dosage and Risk of Sudden Cardiac Arrest.
http://intellewave.net/en/3/32.html | 
